Prednisolone is a glucocorticoid similar to cortisol used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.
Prednisolone was granted FDA approval on 21 June 1955.
Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.
October 6 university hospital, Giza, Egypt
Peking Union Medical College Hospital, Beijing, Bejing, China
Klinik für Hals-, Nasen-, Ohrenheilkunde - Charité Campus Benjamin Franklin - HNO Hochschulambulanz, Berlin, Germany
University Hospital Dresden 'Carl Gustav Carus' - HNO, Dresden, Germany
Evangelisches Krankenhaus - Universitätsklinik für HNO, Oldenburg, Germany
Children's Hospital of Alabama, Birmingham, Alabama, United States
Arkansas Children's Hospital, Little Rock, Arkansas, United States
Kaiser Permanente Downey Medical Center, Downey, California, United States
Peking Union Medical College Hospital, Beijing, China
Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands
Hospìtal Sant Joan de Deu, Barcelone, Spain
Arztpraxis Burgtorstr. 2, Ittlingen, Baden-Württemberg, Germany
Hausarztpraxis Neckarsteinacher Str. 22, Neckargemünd, Baden-Württemberg, Germany
Hausarztpraxis Kleinfeldlein 3, Bad Bocklet, Bayern, Germany
University of Alberta Hospital, Edmonton, Alberta, Canada
USA Health Strada Patient Care Center, Mobile, Alabama, United States
Providence Alaska Medical Center, Anchorage, Alaska, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.